HomeNewsBusinessIndia Inc expects NLP to transform the nation into a global manufacturing hub

India Inc expects NLP to transform the nation into a global manufacturing hub

The NLP is expected to embed India in global supply chains and energise the economy across multiple sectors. It is also expected to enhance green transportation, among others.

September 19, 2022 / 19:26 IST
Story continues below Advertisement
Representative image
Representative image

The National Logistics Policy (NLP) unveiled by Prime Minister Narendra Modi on September 19, is expected to reduce transportation costs across the entire supply chain. It is also expected to catalyse the adoption of technology in the logistics industry, which is still largely made up of unorganised players, industry experts said.

Shashi Kiran Shetty, Founder and Chairman of the Allcargo Group, said the NLP will bring transparency through digital integration, in addition to boosting speed and efficiency.

Story continues below Advertisement

"It will enable fast-paced logistics infrastructure development, better coordination among multiple stakeholders, simplify processes and documentation, and boost last-mile connectivity," Shetty said.

Similarly, Raaho Co-Founder and CEO Mohammed Imthiaz feels that digital freight networks will grow exponentially as a result of the policy, and bring about greener commercial transportation.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show